Insider · CIK 0001479788

Finn John

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001479788

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−95K sh	$8.70	−$826K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−80K sh	$7.37	−$590K	0
2013-09-11	Trius Therapeutics IncD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,230 sh	—	—	0
2013-09-11	Trius Therapeutics IncD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−167K sh	—	—	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−35.8K sh	$12.98	−$465K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−48.8K sh	$12.21	−$596K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−8,138 sh	$12.21	−$99.4K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−50K sh	$10.00	−$500K	0
2013-07-22	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,000 sh	$12.10	−$12.1K	166,860
2013-07-15	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−3,500 sh	$10.55	−$36.9K	167,860
2013-07-12	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−5,000 sh	$10.10	−$50.5K	171,360
2013-07-11	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$9.32	−$4,660	176,360
2013-07-10	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,000 sh	$8.58	−$8,580	176,860
2013-06-12	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−3,000 sh	$9.08	−$27.2K	177,860
2013-06-11	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,000 sh	$8.94	−$8,940	180,860
2013-05-14	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−5,000 sh	$8.10	−$40.5K	181,860
2013-05-10	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−3,000 sh	$7.47	−$22.4K	186,860
2013-05-10	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−3,000 sh	$7.47	−$22.4K	186,860
2013-04-24	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$7.10	−$3,550	189,860
2013-03-15	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,500 sh	$7.10	−$10.7K	190,360
2013-03-07	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2012-03-26	Trius Therapeutics IncStock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	35,813
2012-03-26	Trius Therapeutics IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20K sh	$0.52	+$10.4K	191,860
2012-03-08	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Scientific Officer	AAward	+95K sh	—	—	95,000
2011-10-11	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$6.19	−$3,095	171,860
2011-09-15	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,000 sh	$6.47	−$6,470	172,360
2011-08-12	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−300 sh	$7.00	−$2,100	173,360
2011-08-11	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−200 sh	$7.00	−$1,400	173,660
2011-08-09	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−800 sh	$6.00	−$4,800	173,860
2011-08-09	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−200 sh	$5.82	−$1,164	174,660
2011-07-20	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$8.00	−$4,000	174,860
2011-07-12	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,500 sh	$7.23	−$10.8K	175,360
2011-06-09	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−2,000 sh	$8.09	−$16.2K	176,860
2011-05-16	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−7,000 sh	$8.02	−$56.2K	178,860
2011-05-12	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,500 sh	$7.00	−$10.5K	185,860
2011-05-10	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−1,000 sh	$6.02	−$6,018	187,360
2011-05-03	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−800 sh	$6.00	−$4,800	188,360
2011-04-11	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$5.36	−$2,678	189,160
2011-03-30	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−200 sh	$6.00	−$1,200	189,660
2011-03-09	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$5.86	−$2,930	189,860
2011-03-01	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$7.00	−$3,500	190,360
2011-02-18	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$6.00	−$3,000	190,860
2011-02-17	Trius Therapeutics IncS Sale	Chief Scientific Officer	SSale	−500 sh	$5.00	−$2,500	191,360
2010-11-03	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2010-11-03	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Scientific Officer	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Sep 134
Trius Therapeutics Inc0001209191-13-044242
SEC(opens sec.gov)
Jul 234
Trius Therapeutics Inc0001209191-13-037588
SEC(opens sec.gov)
Jul 164
Trius Therapeutics Inc0001209191-13-036879
SEC(opens sec.gov)
Jul 124
Trius Therapeutics Inc0001209191-13-036534
SEC(opens sec.gov)
Jun 124
Trius Therapeutics Inc0001209191-13-031938
SEC(opens sec.gov)
Jun 114
Trius Therapeutics Inc0001209191-13-031713
SEC(opens sec.gov)
Jun 114/A
Trius Therapeutics Inc0001209191-13-031712
SEC(opens sec.gov)
May 164
Finn John0001209191-13-026744
SEC(opens sec.gov)
May 134
Finn John0001209191-13-025754
SEC(opens sec.gov)
Apr 264
Finn John0001181431-13-023616
SEC(opens sec.gov)
Mar 184
Finn John0001181431-13-017383
SEC(opens sec.gov)

Companies

Trius Therapeutics IncChief Scientific Officer

Address

C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101

SAN DIEGO, CA, 92121